Valuation : Aspen Pharmacare Holdings Limited

Market Cap 69.49B 4.31B 3.72B 3.5B 3.19B 6B 409B 6.03B 41.38B 16.1B 208B 16.19B 15.84B 690B P/E 2026 *
15.9x
P/E 2027 * 13.5x
Enterprise Value 82.37B 5.11B 4.41B 4.15B 3.78B 7.11B 485B 7.15B 49.04B 19.09B 247B 19.2B 18.78B 818B EV / Sales 2026 *
2.19x
EV / Sales 2027 * 1.74x
Free-Float
59.64%
Yield 2026 *
1.7%
Yield 2027 * 1.61%

Last Transcript : Aspen Pharmacare Holdings Limited

1 day-1.14%
1 week+5.25%
Current month-1.14%
1 month+4.96%
3 months+8.66%
6 months+15.57%
Current year+34.00%
1 week 152.65
Extreme 152.65
160.93
1 month 137.96
Extreme 137.96
160.93
Current year 104.38
Extreme 104.38
160.93
1 year 90.7
Extreme 90.7
160.93
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
281.67
10 years 64.07
Extreme 64.07
365.05
Manager TitleAgeSince
Chief Executive Officer 62 1996-12-31
Director of Finance/CFO 61 2008-12-31
Chief Operating Officer 63 1998-12-31
Director TitleAgeSince
Director/Board Member 62 1998-12-31
Director/Board Member 65 1998-12-31
Chairman 58 2015-12-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/27/23 Free

Chief Operating Officer

12,236 0.0027%
9/27/23 Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%+5.25%+49.66%-7.31% 4.31B
+0.14%+1.70%+23.42%+74.20% 48.77B
-1.61%-0.29%+51.58%+118.38% 40.67B
-1.16%+0.37%+15.87%+86.01% 12.27B
-0.72%+0.72%-9.97%+14.04% 12.11B
+0.57%+1.73%+31.59%+153.11% 9.28B
-2.59%-3.98%+22.91%+43.00% 7.55B
-0.42%+0.89%+28.21%+223.05% 7.35B
-0.62%-0.84%+44.70%-11.26% 7.3B
-0.13%-0.16%-40.47%+15.85% 5.25B
Average -0.77%+1.07%+21.75%+70.91% 15.49B
Weighted average by Cap. -0.70%+1.25%+27.86%+84.02%

Financials

2026 *2027 *
Net sales 37.62B 2.34B 2.01B 1.89B 1.73B 3.25B 222B 3.26B 22.4B 8.72B 113B 8.77B 8.58B 374B 38.86B 2.41B 2.08B 1.96B 1.78B 3.35B 229B 3.37B 23.14B 9.01B 116B 9.06B 8.86B 386B
Net income 4.8B 298M 257M 242M 220M 414M 28.26B 416M 2.86B 1.11B 14.38B 1.12B 1.09B 47.67B 5B 310M 267M 252M 229M 431M 29.43B 433M 2.97B 1.16B 14.97B 1.16B 1.14B 49.63B
Net Debt 12.88B 799M 689M 649M 591M 1.11B 75.86B 1.12B 7.67B 2.98B 38.59B 3B 2.94B 128B -1.74B -108M -92.91M -87.39M -79.62M -150M -10.22B -151M -1.03B -402M -5.2B -404M -396M -17.24B
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
26-09-01 ZAR 156.50 -1.14% 1,252,513
26-08-31 ZAR 158.30 -0.23% 1,232,864
26-08-28 ZAR 158.67 -1.16% 794,415
26-08-27 ZAR 160.53 +3.92% 1,774,062
26-08-26 ZAR 154.48 +3.89% 1,838,982
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
156.50ZAR
Average target price
162.75ZAR
Spread / Average Target
+3.99%

Annual profits - Rate of surprise